Clinical Trials in Maryland

Browse 243 Maryland Medical Studies Across 1234 Cities
99 Phase 3 Trial · 9894 Maryland Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Maryland

Reviewed by Michael Gill, B. Sc.

Image of Johns Hopkins University in Baltimore, United States.

Phase-Based Progress Estimates

SWAN Motion Sick Daytonfor Vestibular Schwannomas

The investigators have developed a self-administered rehabilitation tool that incrementally guides the user to increase head motion to mitigate motion sickness and enhance postural recovery following centrifugation or unilateral vestibular nerve deafferentation surgery.

Johns Hopkins University (+1 Sites)Matthew Stewart, MD PhD

Image of Neighborhood Healthcare Institute of Health in Escondido, United States.

Phase-Based Progress Estimates

Tirzepatidefor Overweight

This trial will look at whether tirzepatide can reduce obesity-related health problems and death in adults.

Neighborhood Healthcare Institute of Health (+78 Sites)Call 1-877-CTLILLY (1-877-285-4559 or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company

Image of Care Access Mobile Site in New London, United States.

Phase-Based Progress Estimates

VLA15for Lyme Disease

Senior-friendly

This trial is being conducted to test the safety and effectiveness of a Lyme disease vaccine.

Senior-friendly

Care Access Mobile Site (+57 Sites)Pfizer CT.gov Call CenterValneva Austria GmbH

Image of Sarah Cannon Research Institute in Nashville, United States.

Phase-Based Progress Estimates

JNJ-80038114for Prostate Cancer

This trial is testing a new drug to find the best dose for safety and effectiveness.

Sarah Cannon Research Institute (+3 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC

Image of Novo Nordisk Investigational Site in Roswell, United States.

Phase-Based Progress Estimates

IcoSemafor Diabetes Mellitus, Type 2

This trial will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin icodec taken once a week in people with type 2 diabetes, in terms of blood sugar control.

Novo Nordisk Investigational Site (+62 Sites)Clinical Transparency (dept. 2834)Novo Nordisk A/S

Image of University of Maryland School of Medicine in Baltimore, United States.

Phase-Based Progress Estimates

Remote Monitoringfor Ileocolitis

This trial will help assess whether or not a remote monitoring digital health system can improve adherence, clinical outcomes, and decrease healthcare utilization compared to standard care in participants with inflammatory bowel disease.

University of Maryland School of Medicine

Image of Retina-Vitreous Associates Medical Group in Beverly Hills, United States.

Phase-Based Progress Estimates

UBX1325for Age related macular degeneration

This trial will test if it is safe to give patients with wet AMD another injection of UBX1325.

Retina-Vitreous Associates Medical Group (+25 Sites)Unity Biotechnology, Inc.

Image of Prometheus Biosciences Selected Site in Los Angeles, United States.

Phase-Based Progress Estimates

PRA023 IVfor Diffuse Scleroderma

This trial is testing a new drug to see if it's safe and effective for people with a lung disease called SSc-ILD.

Prometheus Biosciences Selected Site (+9 Sites)Prometheus BiosciencesPrometheus Biosciences, Inc.

Image of City of Hope in Duarte, United States.

Phase-Based Progress Estimates

Daratumumabfor Amyloidosis

This trial is testing a new cancer treatment to see if it is safe for people with heart problems. The new treatment is a combination of drugs, and the trial will also look at how well it works in people of different racial and ethnic backgrounds.

City of Hope (+17 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC

Image of Alta Bates Summit Medical Center-Herrick Campus in Berkeley, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Stage IVA Lung Cancer AJCC v8

FDA Approved Drug

This trial is testing immunotherapy treatment with N-803 and pembrolizumab for advanced non-small cell lung cancer. N-803 may activate natural killer cells so that they can stimulate an immune response to help fight cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

FDA Approved Drug

Alta Bates Summit Medical Center-Herrick Campus (+99 Sites)John M Wrangle

Image of MDACC in Houston, United States.

Phase-Based Progress Estimates

DSP-5336for Leukemia, Myeloid, Acute

This trial is testing a new drug for people with a certain type of blood cancer who have not responded to other treatments.

MDACC (+5 Sites)Sumitomo Dainippon Pharma Oncology, Inc

Image of University of Washinton in Seattle, United States.

Phase-Based Progress Estimates

Facilitated Group Supportfor Endometrial Neoplasms

This trial is looking at whether social support can help Black patients with endometrial cancer finish their treatment.

University of Washinton (+8 Sites)Kemi M Doll, MD, MS

Image of Care Access Research LLC in Berkeley, United States.

Phase-Based Progress Estimates

CDPATH™for Crohn Disease

This trial is testing a tool to help predict Crohn's disease complications and to aid discussions with doctors about the disease.

Care Access Research LLC (+73 Sites)Study DirectorTakeda

Image of Colorado Vision Institute in Colorado Springs, United States.

Phase-Based Progress Estimates

OT-101 Ophthalmic Solutionfor Myopia

This trial is testing if atropine sulfate can treat myopia in children. It is a safety, tolerability, and efficacy study, which means they are testing how well and how safe the drug is.

Colorado Vision Institute (+14 Sites)Keith LaneORA, Inc.

Image of AES - DRS - Simon Williamson Clinic, PC - Birmingham in Birmingham, United States.

Phase-Based Progress Estimates

CC-93538for Eosinophilic Esophagitis

This trial is testing a new medication for people with Eosinophilic Esophagitis. The trial has two phases, induction and maintenance, each lasting 24 weeks. There are three treatment groups, one receiving a placebo and two receiving the trial medication.

AES - DRS - Simon Williamson Clinic, PC - Birmingham (+99 Sites)Cristian Rodriguez, MDCelgene

Image of HonorHealth Research Institute in Scottsdale, United States.

Phase-Based Progress Estimates

PVSRIPOfor Melanoma

This trial is testing a new cancer drug to see if it is effective and safe when used alone or with another cancer drug.

HonorHealth Research Institute (+24 Sites)Istari Oncology, Inc.

Image of Regeneron Study Site in Birmingham, United States.

Phase-Based Progress Estimates

Dupilumabfor Allergic Bronchopulmonary Aspergillosis

FDA Approved Drug

This trial will study the effects of the medication dupilumab on people with Allergic Bronchopulmonary Aspergillosis, specifically looking at the rate of exacerbations, lung function, health-related quality of life, and other measures.

FDA Approved Drug

Regeneron Study Site (+23 Sites)Clinical Trial ManagementSanofi

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Radiation Therapyfor Breast

FDA Approved Drug

This trial is studying how well paclitaxel, trastuzumab, and pertuzumab work in eliminating chemotherapy after surgery in patients with HER2-positive stage II-IIIa breast cancer who have no cancer remaining at surgery.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Nadine M Tung

Image of Fairbanks Memorial Hospital in Fairbanks, United States.

Phase-Based Progress Estimates

Regional Radiotherapyfor Breast Cancer

This trial is testing whether omitting regional radiation therapy for low-risk breast cancer is non-inferior to usual care.

Fairbanks Memorial Hospital (+99 Sites)Timothy Whelan

Image of University of California, Los Angeles in Los Angeles, United States.

Phase-Based Progress Estimates

DS-1062afor Breast Cancer

This trial is studying a new drug, DS-1062a, for safety and tolerability in people with NSCLC that has not been cured by other treatments. The trial will be in two parts, with the first part looking at dose escalation and the second part looking at additional solid tumors. The trial is expected to last approximately 6 years and will be conducted in the United States and Japan.

University of California, Los Angeles (+11 Sites)Global Team LeaderDaiichi Sankyo, Inc.

Image of Applied Research of Arkansas in Little Rock, United States.

Phase-Based Progress Estimates

Eluxadolinefor Irritable Bowel Syndrome

FDA Approved Drug

This trial is testing whether eluxadoline is an effective and safe treatment for IBS-D in children 6-17 years old.

FDA Approved Drug

Applied Research of Arkansas (+47 Sites)Taryn Weissman, MDAllergan

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Autologous Hematopoietic Stem Cell Transplantationfor Mantle Cell Lymphoma (MCL)

FDA Approved Drug

This trial is testing if rituximab works better with or without stem cell transplant for mantle cell lymphoma in patients who are in first complete remission.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Timothy Fenske

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Ipilimumabfor Serous Cystadenocarcinoma

FDA Approved Drug

This trial is studying nivolumab and ipilimumab in treating patients with rare tumors.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Sandip P Patel

Image of Zuckerberg San Francisco General Hospital in San Francisco, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Cancer of Skin

FDA Approved Drug

This trial studies the side effects of pembrolizumab in treating patients with HIV and cancer.

FDA Approved Drug

Zuckerberg San Francisco General Hospital (+10 Sites)Kathryn Lurain

Image of Yale School of Medicine in New Haven, United States.

Phase-Based Progress Estimates

Merotocinfor Inadequate Milk Production

This trial looks at whether a drug can help women with preterm babies and low milk production to make more milk.

Yale School of Medicine (+18 Sites)Global Clinical ComplianceFerring Pharmaceuticals

25 Maryland Clinical Trials Near Me

Top Cities for Maryland Clinical Trials

Image of Baltimore in Maryland.

Baltimore

180Active Trials

Johns Hopkins UniversityTop Active Site

Image of Los Angeles in California.

Los Angeles

159Active Trials

Kaiser Permanente Los Angeles Medical CenterTop Active Site

Image of Chicago in Illinois.

Chicago

133Active Trials

Northwestern UniversityTop Active Site